Diabetes, Prediabetes, and Glycemic Control in the United States: Challenges and Opportunities

Editorials15 April 2014Diabetes, Prediabetes, and Glycemic Control in the United States: Challenges and OpportunitiesRoeland J.W. Middelbeek, MD and Martin J. Abrahamson, MDRoeland J.W. Middelbeek, MDFrom Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts. and Martin J. Abrahamson, MDFrom Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M14-0539 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Over the past several decades, U.S. obesity rates have increased dramatically. Today, more than one third of U.S. adults are obese (1). This increase has been attributed to many factors (most notably, dietary changes and lack of physical activity). A concomitant increase in type 2 diabetes parallels the increased incidence of obesity. Type 2 diabetes represents more than 90% of all diabetes cases and is associated with many complications, including neuropathy, retinopathy, nephropathy, and cardiovascular and cerebrovascular disease. The cost of diabetes and its complications was estimated to be $245 billion in 2012, representing approximately 9% of the health care ...References1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief. 2013;:1-8. [PMID: 24152742] MedlineGoogle Scholar2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-46. [PMID: 23468086] CrossrefMedlineGoogle Scholar3. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med. 2014;160:517-25. LinkGoogle Scholar4. American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33 Suppl 1 S11-61. [PMID: 20042772] CrossrefMedlineGoogle Scholar5. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33:562-8. [PMID: 20067953] CrossrefMedlineGoogle Scholar6. Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97:1579-639. [PMID: 22730516] CrossrefMedlineGoogle Scholar7. Grant RW, Buse JB, Meigs JB; University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-442. [PMID: 15677789] CrossrefMedlineGoogle Scholar8. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. [PMID: 11832527] CrossrefMedlineGoogle Scholar9. Moyer VA; U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:373-8. [PMID: 22733087] AbstractGoogle Scholar10. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013;159:543-51. [PMID: 24126648] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-0539.Corresponding Author: Martin J. Abrahamson, MD, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215; e-mail, martin.[email protected]harvard.edu.Current Author Addresses: Drs. Middelbeek and Abrahamson: Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoTrends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010 Elizabeth Selvin , Christina M. Parrinello , David B. Sacks , and Josef Coresh Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010 Elizabeth Selvin , Christina M. Parrinello , David B. Sacks , and Josef Coresh Metrics Cited byOutcomes in prediabetes vs. diabetes in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous interventionAssociation between dietary patterns and prediabetes risk in a middle-aged Chinese populationBeta-Blocker and Renin–Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry StudyPre-diabetes and cardiovascular risk: detonating the time bombPrediyabet Tanılı Hastaların Sosyodemografik ve Klinik Durumları ve Engellilik ile İlişkisiVirtual Coaching to Enhance Diabetes CarePrediabetes and Cardiovascular DiseaseHealthy and unhealthy dietary patterns are related to pre-diabetes: a case–control studyPrevalence, awareness and risk factors of diabetes in Ahvaz (South West of Iran) 15 April 2014Volume 160, Issue 8Page: 572-573KeywordsBlood plasmaDiabetes preventionExerciseGlucoseHbA1cHealth careHealth surveysInsulinObesityType 2 diabetes ePublished: 15 April 2014 Issue Published: 15 April 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...